Karmanos Cancer Institute Seeks Breast Cancer Patients To Participate In A New Drug T

[News]

The Barbara Ann Karmanos Institute is looking for women with HER2 positive metastatic breast cancer to participate in a clinical trial. The Phase II trial at Karmanos is part of an international study to further test a new drug Trastuzumab-DM1, in development by Genentech. The trial will be under the direction of Patricia LoRusso, D.O.

More... (http://www.medicalnewstoday.com/articles/128854.php)